Sernova Set to Improve the Treatment of Chronic Diseases

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Imagine there is a person with diabetes who must focus on measuring their blood sugar levels almost constantly followed by injection of insulin multiple times each day or monitoring their insulin pump delivery to keep their diabetes under control. And yet, to make matters worse, they still have the potential to develop the serious long-term complications of diabetes, such as cardiovascular disease, blindness, and amputations. And, for the approximately 30% of people with Type 1 diabetes who have hypoglycemia unawareness, every insulin injection has the potential to severely drop their blood sugar levels to dangerous levels without being aware.

London, Ontario-based Sernova Corp. (TSXV: SVA), is developing a better way to treat the disease involving the replacement of lost pancreatic islets, whose function is to read blood sugar levels and release insulin into the blood, normalizing blood sugar levels.

http://www.digitaljournal.com/pr/1694745
 
Status
Not open for further replies.
Back
Top